http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105777905-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-241
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
filingDate 2016-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2019-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105777905-B
titleOfInvention A kind of full source of people anti-tnf-alpha monoclonal antibody and its application
abstract The present invention relates to field of biotechnology, it is specifically related to a kind of full source of people anti-tnf-alpha monoclonal antibody, amino acid sequence of the heavy chain variable region with amino acid sequence shown in SEQ ID NO:1 or the homology for having at least 98% with it, amino acid sequence of the light chain variable region with amino acid sequence shown in SEQ IDNO:2 or the homology for having at least 98% with it.In addition invention also discloses a kind of DNA sequence dnas of above-mentioned novel full source of people anti-tnf-alpha monoclonal antibody, heavy chain variable region nucleotide coding is nucleotide sequence shown in SEQ ID NO:3, and light chain variable region nucleotide coding is nucleotide sequence shown in SEQ ID NO:4.The invention discloses application prospect of the source of people anti-tnf-alpha monoclonal antibody in preparation treatment autoimmune disease drug.
priorityDate 2015-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415824599
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID36054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123865
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID554167
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID114461
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397086
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10029
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID494186
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID744399
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520247
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10029
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100126739

Total number of triples: 36.